Niederhuber John's Form 4 filing
Aptevo Therapeutics Inc. (APVO) · filed Jun 3, 2022
- Accession no.
- 0001209191-22-033928
- Filed
- Jun 3, 2022
- Trade date
- Jun 14, 2019-Jun 1, 2022
- Filing delay
- 1,085 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $649.74. It was filed 1085 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Niederhuber JohnCIK 0001501240 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2019 | Common Stock | PPurchaseAcquired | +714 | $0.91 | +$649.74 | 1,516 | Direct | |
| Jun 1, 2022 | Common Stock | MOption exerciseAcquired | +298 | – | – | 1,814 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Common Stock | MOption exerciseDisposed | −298 | $0.00 | $0 | 595 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.